Diphtheria Completed Phase 3 Trials for Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen (DB14428)

Also known as: Corynebacterium diphtheriae infection / Infection due to Corynebacterium diphtheriae (disorder) / Diphtheria caused by Corynebacterium diphtheriae (disorder) / Diphtheria, unspecified

IndicationStatusPhase
DBCOND0000394 (Diphtheria)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00463437Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same VaccinesPrevention
NCT00317187Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.Prevention
NCT00317135Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.Prevention
NCT00136604Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30mPrevention